Outcomes of Uterine Conservation in Placenta Accreta Spectrum
Short and Intermediate Term Outcomes of Uterine Conservation After Cesarian Section in Cases of Placenta Accreta Spectrum
This study looks at how well uterine conservation procedures work for women with placenta accreta spectrum by tracking their recovery, blood loss, and menstrual return after the surgery.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 120 (estimated) |
| Ages | 20 Years to 40 Years |
| Sex | Female |
| Sponsor | Alexandria University Academic / other |
| Locations | 1 site (Alexandria, Alexandria Governorate) |
| Trial ID | NCT04866888 on ClinicalTrials.gov |
What this trial studies
This study focuses on patients diagnosed with placenta accreta spectrum who undergo uterine conservation procedures. It aims to document the immediate outcomes of these procedures, including success rates, blood loss, and transfusion requirements. Participants will be monitored for the return of menstruation and any uterine abnormalities through ultrasound or hysteroscopy. Data will be collected on various factors such as obstetric history, anthropometry, and laboratory investigations to assess the overall impact of the intervention.
Who should consider this trial
Good fit: Ideal candidates are pregnant women diagnosed with singleton placenta accreta spectrum who are scheduled for elective cesarean section.
Not a fit: Patients requesting hysterectomy or those with significant coexisting uterine pathologies may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve management strategies for placenta accreta spectrum, potentially preserving fertility and reducing complications.
How similar studies have performed: While there have been studies on placenta accreta spectrum, this specific approach to uterine conservation is relatively novel and may provide new insights.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * • Diagnosed sonographically to have placenta accreta spectrum. * Pregnancy is singleton and fetus is alive. * Elective caesarean section done from 35 gestational weeks. Exclusion Criteria: * • Patients requesting hysterectomy. * Coexisting uterine pathology such as fibroids or gynaecological malignancies. * Patients with bleeding diathesis. * Morbid obesity of BMI \>40. * Patients having labour pains or vaginal bleeding before scheduled intervention.
Where this trial is running
Alexandria, Alexandria Governorate
- Faculty of Medicine — Alexandria, Alexandria Governorate, Egypt (Recruiting)
Study contacts
- Study coordinator: Omar Y Elshorbagy, As.lec
- Email: o_kamal13@alexmed.edu.eg
- Phone: 01111362322
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.